Pfizer Limited (PFIZER) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.156x

Based on the latest financial reports, Pfizer Limited (PFIZER) has a cash flow conversion efficiency ratio of 0.156x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.99 Billion ≈ $64.83 Million USD) by net assets (Rs38.48 Billion ≈ $416.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Pfizer Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Pfizer Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Pfizer Limited (PFIZER) total liabilities for a breakdown of total debt and financial obligations.

Pfizer Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pfizer Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tiger Brands Ltd JSE:TBS	0.166x
BaoJi Titanium Industry Co Ltd SHG:600456	0.022x
Civitas Resources Inc NYSE:CIVI	0.129x
Kangwon Land KO:035250	0.030x
Sendas Distribuidora S.A. SA:ASAI3	0.387x
Shanghai Beite Technology Co SHG:603009	0.035x
Lien Hwa Industrial Corp TW:1229	0.020x
Tokai Carbon Korea Co. Ltd KQ:064760	0.032x

Annual Cash Flow Conversion Efficiency for Pfizer Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Pfizer Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Pfizer Limited market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs42.17 Billion ≈ $456.10 Million	Rs6.60 Billion ≈ $71.35 Million	0.156x	+119.00%
2024-03-31	Rs35.96 Billion ≈ $388.84 Million	Rs2.57 Billion ≈ $27.78 Million	0.071x	-35.59%
2023-03-31	Rs32.07 Billion ≈ $346.86 Million	Rs3.56 Billion ≈ $38.47 Million	0.111x	-52.38%
2022-03-31	Rs28.64 Billion ≈ $309.78 Million	Rs6.67 Billion ≈ $72.14 Million	0.233x	+30.42%
2021-03-31	Rs23.93 Billion ≈ $258.80 Million	Rs4.27 Billion ≈ $46.21 Million	0.179x	+87.62%
2020-03-31	Rs33.95 Billion ≈ $367.21 Million	Rs3.23 Billion ≈ $34.95 Million	0.095x	+193.03%
2019-03-31	Rs30.11 Billion ≈ $325.66 Million	Rs978.10 Million ≈ $10.58 Million	0.032x	-73.73%
2018-03-31	Rs26.83 Billion ≈ $290.18 Million	Rs3.32 Billion ≈ $35.88 Million	0.124x	-9.03%
2017-03-31	Rs24.19 Billion ≈ $261.59 Million	Rs3.29 Billion ≈ $35.56 Million	0.136x	-16.22%
2016-03-31	Rs21.18 Billion ≈ $229.05 Million	Rs3.44 Billion ≈ $37.16 Million	0.162x	+182.10%
2015-03-31	Rs19.73 Billion ≈ $213.37 Million	Rs1.13 Billion ≈ $12.27 Million	0.058x	-71.41%
2014-03-31	Rs6.58 Billion ≈ $71.20 Million	Rs1.32 Billion ≈ $14.32 Million	0.201x	+4060.27%
2013-03-31	Rs16.94 Billion ≈ $183.25 Million	Rs-86.07 Million ≈ $-930.79K	-0.005x	-127.10%
2012-03-31	Rs13.05 Billion ≈ $141.10 Million	Rs244.59 Million ≈ $2.65 Million	0.019x	-86.64%
2011-03-31	Rs11.63 Billion ≈ $125.82 Million	Rs1.63 Billion ≈ $17.66 Million	0.140x	+86.88%
2010-03-31	Rs9.94 Billion ≈ $107.53 Million	Rs746.73 Million ≈ $8.08 Million	0.075x	-71.54%
2009-03-31	Rs9.01 Billion ≈ $97.45 Million	Rs2.38 Billion ≈ $25.71 Million	0.264x	+941.98%
2008-03-31	Rs6.50 Billion ≈ $70.26 Million	Rs164.53 Million ≈ $1.78 Million	0.025x	-90.96%
2007-03-31	Rs4.40 Billion ≈ $47.56 Million	Rs1.23 Billion ≈ $13.32 Million	0.280x	+2.51%
2006-03-31	Rs3.76 Billion ≈ $40.66 Million	Rs1.03 Billion ≈ $11.11 Million	0.273x	+6.40%
2005-03-31	Rs3.40 Billion ≈ $36.72 Million	Rs872.08 Million ≈ $9.43 Million	0.257x	--

About Pfizer Limited

NSE:PFIZER India Drug Manufacturers - General

Market Cap

$2.33 Billion

Rs215.50 Billion INR

Market Cap Rank

#5706 Global

#246 in India

Share Price

Rs4710.60

Change (1 day)

-1.10%

52-Week Range

Rs4243.60 - Rs5889.00

All Time High

Rs6318.30